SAMHD1 and mantle cell lymphoma: Because most cases of MCL included in clinical studies are of the conventional subtype and thus SOX11+21,22 (in contrast to the more indolent, nonnodal leukemic MCL variant that is SOX11 negative23), it can be inferred that SAMHD1 is inherently inhibited by SOX11.